Pfizer Shares Patient Letter re Voxelotor (Oxybryta®) Withdrawal

Posted 21st October 2024

Posted 7 months ago

By Pfizer

Features New Therapies Patient Guidelines Publications

Pfizer Shares Patient Letter re Voxelotor (Oxybryta®) Withdrawal

Pfizer Shares Patient Advice Regarding Immediate Withdrawal of Voxelotor (Oxybryta®)

Read More
Voxelotor (Oxbryta®) Withdrawal - NHP Patient Letter

Posted 10th October 2024

Posted 7 months ago

By NHP Office

Features New Therapies News & Updates Patient Guidelines Publications

Voxelotor (Oxbryta®) Withdrawal - NHP Patient Letter

Following the unforeseen Pfizer withdrawal of Voxelotor (Oxbryta®) Medication for Sickle Cell Disease on 25th September 2024, the NHP provided a letter assist affected Sickle Cell Disorder patients.

Read More